Company intelligence / Profile preview
Beijing Tianli Zhengyuan Pharmaceutical Technology Development
- Ownership
- Private
- Development stage
- Other
Overview
Beijing Tianli Zhengyuan Pharmaceutical Technology Development is a Chinese biotechnology company focused on the research and development of innovative small molecule therapeutics, particularly for metabolic diseases. The company has advanced several candidates into clinical trials, including novel inhibitors targeting SGLT2 and DPP-4 for the treatment of type 2 diabetes. Their business model encompasses the full drug development lifecycle from discovery and preclinical evaluation to clinical trial management. Beijing Tianli Zhengyuan aims to provide high-quality, affordable pharmaceutical solutions to address significant unmet medical needs in the domestic Chinese market and beyond.
- Therapeutic areas
- Endocrinology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Beijing Tianli Zhengyuan Pharmaceutical Technology Development.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Tianli Zhengyuan Pharmaceutical Technology Development.